|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest income earned on investments held in Trust Account | |
| Realized gain on NMSI warrants | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Deferred offering costs | |
| Accrued expenses | |
| Accrued offering costs | |
| Due to related party | |
| Net Cash Used in Operating Activities | |
| Cash Flows from Investing Activities: | |
| Cash deposited into Trust Account | |
| Net Cash Used in Investing Activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from the sale of Units | |
| Proceeds from promissory note - related party | |
| Payment of promissory note - related party | |
| Proceeds from sale of private placement warrants | |
| Payment of underwriting fee | |
| Payment of offering costs | |
| Net Cash Provided by Financing Activities | |
| Net change in cash | |
| Cash at beginning of period | |
| Cash at end of period | |
| Supplemental disclosure of non-cash financing activities: | |
| Deferred underwriters' discount payable |
Loading...
